Stay updated with breaking news from Director Eric. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Profund Advisors LLC grew its stake in Biogen Inc. (NASDAQ:BIIB – Free Report) by 26.6% during the 3rd quarter, HoldingsChannel reports. The fund owned 17,041 shares of the biotechnology company’s stock after purchasing an additional 3,584 shares during the quarter. Profund Advisors LLC’s holdings in Biogen were worth $4,380,000 as of its most recent SEC […]
Cantor Fitzgerald restated their overweight rating on shares of Biogen (NASDAQ:BIIB – Free Report) in a research note released on Tuesday, Benzinga reports. Cantor Fitzgerald currently has a $311.00 price target on the biotechnology company’s stock. Several other equities research analysts have also recently issued reports on BIIB. Wells Fargo & Company cut Biogen from […]
Cantor Fitzgerald restated their overweight rating on shares of Biogen (NASDAQ:BIIB – Free Report) in a research report sent to investors on Tuesday, Benzinga reports. The firm currently has a $311.00 target price on the biotechnology company’s stock. Several other research analysts have also recently issued reports on BIIB. Stifel Nicolaus dropped their price target […]
ABI Research's latest whitepaper highlights 38 transformative technology stats you need to know for 2024 and beyond
Biogen (NASDAQ:BIIB – Get Free Report) had its price target cut by Mizuho from $355.00 to $277.00 in a research note issued to investors on Thursday, Benzinga reports. The brokerage presently has a “buy” rating on the biotechnology company’s stock. Mizuho’s price objective indicates a potential upside of 25.31% from the stock’s previous close. Other […]